Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mammalian
HELQ
is a 3'-5' DNA helicase with strand displacement activity. Here we show that
HELQ
participates in a pathway of resistance to DNA interstrand crosslinks (ICLs). Genetic disruption of
HELQ
in human cells enhances cellular sensitivity and chromosome radial formation by the ICL-inducing agent mitomycin C (MMC). A significant fraction of MMC sensitivity is independent of the Fanconi anaemia pathway. Sister chromatid exchange frequency and sensitivity to UV radiation or
topoisomerase
inhibitors is unaltered. Proteomic analysis reveals that
HELQ
is associated with the RAD51 paralogs RAD51B/C/D and XRCC2, and with the DNA damage-responsive kinase ATR. After treatment with MMC, reduced phosphorylation of the ATR substrate CHK1 occurs in
HELQ
-knockout cells, and accumulation of G2/M cells is reduced. The results indicate that
HELQ
operates in an arm of DNA repair and signalling in response to ICL. Further, the association with RAD51 paralogs suggests
HELQ
as a candidate ovarian cancer gene.
...
PMID:Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs. 2400 65